THERAVANCE INC's ticker is and the CUSIP is 88338TAB0. A total of 19 filers reported holding THERAVANCE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $5,169,000 | +1.3% | 4,748,000 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $5,101,000 | -1.4% | 4,748,000 | -6.7% | 0.01% | 0.0% |
| Q2 2021 | $5,174,000 | +1.6% | 5,091,000 | 0.0% | 0.01% | -16.7% |
| Q1 2021 | $5,094,000 | +35.6% | 5,091,000 | +34.8% | 0.01% | +50.0% |
| Q4 2020 | $3,758,000 | +3.9% | 3,778,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $3,616,000 | +1.5% | 3,778,000 | +4.7% | 0.00% | -20.0% |
| Q2 2020 | $3,563,000 | -23.7% | 3,610,000 | -28.1% | 0.01% | -28.6% |
| Q1 2020 | $4,670,000 | -7.2% | 5,024,000 | 0.0% | 0.01% | +16.7% |
| Q4 2019 | $5,035,000 | +6.8% | 5,024,000 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $4,716,000 | -10.5% | 5,024,000 | 0.0% | 0.01% | -14.3% |
| Q2 2019 | $5,269,000 | +29.7% | 5,024,000 | +25.5% | 0.01% | +40.0% |
| Q1 2019 | $4,062,000 | -16.2% | 4,004,000 | -10.8% | 0.01% | -28.6% |
| Q4 2018 | $4,849,000 | – | 4,487,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kamunting Street Capital Management, L.P. | 4,763,000 | $4,647,000 | 2.94% |
| Wellesley Asset Management | 41,692 | $40,884,000 | 2.19% |
| LINDEN ADVISORS LP | 33,745,000 | $32,969,000 | 1.17% |
| BASSO CAPITAL MANAGEMENT, L.P. | 6,475,000 | $6,304,000 | 0.78% |
| Castle Creek Arbitrage, LLC | 7,570,000 | $7,394,000 | 0.74% |
| SSI INVESTMENT MANAGEMENT LLC | 6,713,000 | $6,551,000 | 0.56% |
| OAKTREE CAPITAL MANAGEMENT LP | 25,290,000 | $24,630,000 | 0.37% |
| IRON Financial LLC | 485,000 | $475,000 | 0.36% |
| AQR Arbitrage LLC | 31,218,000 | $30,613,000 | 0.33% |
| Man Investments (CH) AG | 300,000 | $293,000 | 0.25% |